Gradalis replaced fragmented, paper-based records across autologous cell manufacturing, quality control, and clinical operations with the L7|ESP® platform. It digitizes Vigil® batch production, connects instrument data to electronic records, and enables barcode-based sample tracking while maintaining chain of identity and custody and improving traceability, compliance, process control, and efficiency.
To access this resource, please make sure to accept cookies.